相关实验视频
Updated: Jul 18, 2025

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
1.7K
被编程细胞死亡蛋白1诱导的过度甲状腺功能低下症的替代剂量抗体可能高于推剂量
Qian Zhang1, Yao Zhang2, Huijuan Zhu3
1Department of Medical Oncology, Affiliated Hospital of Hebei University, Hebei Key Laboratory of Cancer Radiotherapy and Chemotherapy, Baoding, Hebei, 071000, China.
Endocrine, metabolic & immune disorders drug targets
|August 22, 2023
概括
这项研究确定了通过编程细胞死亡蛋白1 (PD-1) 治疗诱导的甲状腺功能低下症的最佳levothyroxine替代剂量. 在PD-1相关的甲状腺功能低下症患者中,平均维持剂量为1.8μg/kg/天.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 由于编程细胞死亡蛋白1 (PD-1) 治疗导致的甲状腺功能低下症的管理,目前的指导方针缺乏统一性.
- 临床试验很少研究这种特定疾病的最佳替代剂量.
研究的目的:
- 描述由PD-1抗体 (Abs) 诱导的甲状腺功能低下症的临床特征.
- 在接受PD-1治疗的患者中,为低甲状腺症建立推的替代剂量.
主要方法:
- 对18名明显患有PD-1诱导的原发性甲状腺功能低下症的患者进行了回顾性分析.
- 替代剂量与18名年龄和性别匹配的自然发生的明显原发性甲状腺功能低下症患者的比较.
主要成果:
- 甲状腺功能低下的发病发生在PD-1治疗中位数为87.5天后.
- 大多数患者无症状,发病不依赖年龄,性别或甲状腺抗体.
- 平均需要的levothyroxine替代剂量为1.8μg/kg/天.
结论:
- 对于PD-1 Abs诱导的甲状腺功能低下症,Levothyroxine的平均维持剂量似乎是1.8μg/kg/天.
- 本剂量建议旨在标准化对这种新出现的临床挑战的治疗.
相关概念视频
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
Cell-mediated Immune Responses
68.9K
Overview
68.9K
Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Synthesis and Regulation of Thyroid Hormones
4.7K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.7K

